Intervention

RIC

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting1

Common conditions4

Lead sponsors shown3

Clinical trials

3 shown

Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...NCT05470491 · 2023-01-26

Efficacy of Remote Ischemic Conditioning for Hypertension in High-Altitude Immigrant PopulationsNCT07562477 · 2026-05-10

NOT_YET_RECRUITING

Remote Ischemic Conditioning for the Treatment of Resistant HypertensionNCT05426707 · 2022-10-01

Common conditions

Hematologic Malignancies1 HIV1 Hypertension1 Resistant Hypertension1

Leading sponsors

Capital Medical University1 Ji Xunming,MD,PhD1 National Cancer Institute (NCI)1

Trial status mix

NOT_YET_RECRUITING1

RECRUITING1

UNKNOWN1

Phase mix

NA1

PHASE11

PHASE21

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.